Navigation Links
Homeless cells find temporary lodging -- and their demise
Date:11/29/2007

BOSTON, Mass. (Nov. 29, 2007)Sometimes healthy cells commit suicide. In the 1970s, scientists showed that a type of programmed cell death called apoptosis plays a key role in development, and the 2002 Nobel Prize in Physiology or Medicine recognized their work. As apoptotic cells degrade, they display standard characteristics, including irregular bulges in the membrane and nuclear fragmentation.

Now, Harvard Medical School researchers have uncovered a new type of death devoid of these features. In the Nov. 30 issue of Cell, they report a bizarre cell-in-cell invasion and death process, which they name entosis, after the Greek word for within.

We watched homeless cells, free of their normal attachments, bore into their neighbors and die inside compartments called vacuoles, says Michael Overholtzer, a postdoctoral researcher in Joan Brugges lab.

Were not sure if entosis evolved to play a particular role or if its simply an aberration of a normal process, adds Brugge, who is Chair of the Department of Cell Biology.

Overholtzer discovered entosis while working with human breast cells that normally form sheets of tissue. When these cells become detached from their protein-rich beds, they generally die through apoptosis. But Overholtzer noticed that they behave oddly long before displaying apoptotic features. In fact, many of these homeless cells actually nest inside their neighbors.

Further experimentation revealed that the cells actively invade neighboring cells. While some of the intruderswhich initially appear healthylater exit their hosts unharmed, most die inside vacuoles.

But Overholtzer didnt realize the implications of his initial observation until he crossed paths with Brigham and Womens Hospital pathologist Andrea Richardson. She informed him that the scientific literature is full of cell-in-cell references in the context of cancer.

Although these structures have been described by pathologists
'/>"/>

Contact: Alyssa Kneller
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. $8,000 Winning Bids at Governors Livestock Auction to Benefit College-Bound Youth and Homeless
2. United Way of Greater Los Angeles Kicks Off Initiative to Prevent and End Homelessness With HomeWalk 2007
3. The Jericho Project Announces Rehabilitation Residence for Homeless and Low-Income Veterans
4. Homeless Vets - VA Sets the Record Straight
5. New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves
6. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
7. Brain cells work differently than previously thought
8. Embryonic Stem Cells Repair Human Heart
9. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
10. Circulating fats kill transplanted pancreas cells, study shows
11. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Do Charitable Gift Donations Make a Difference? 2Health News:Bridgepoint Education's University of the Rockies Introduces New Master of Arts Specialization in Career Management and Counseling 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 5Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 6Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 7Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 8Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 9Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 10Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 11Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 12Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 13Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 14Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 15Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 16Health News:WebMD Health Corp. Announces Preliminary Results of Its Tender Offer 2Health News:WebMD Health Corp. Announces Preliminary Results of Its Tender Offer 3Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 2Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 3Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 4Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 5Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 6
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3The YogaForce A Line Mat Provides The Perfect Solution For Fitness Needs 62204 1The YogaForce A Line Mat Provides The Perfect Solution For Fitness Needs 62204 2The YogaForce A Line Mat Provides The Perfect Solution For Fitness Needs 62204 3New Study Finds Men and Women May Respond Differently to Danger 6558 1New Study Finds Men and Women May Respond Differently to Danger 6558 2New Study Finds Men and Women May Respond Differently to Danger 6558 3Siemens Introduces Its New Power Couple at RSNA 2009 6557 1Siemens Introduces Its New Power Couple at RSNA 2009 6557 2Siemens Introduces Its New Power Couple at RSNA 2009 6557 3Siemens Introduces Its New Power Couple at RSNA 2009 6557 4Siemens Introduces Its New Power Couple at RSNA 2009 6557 5Siemens Introduces Its New Power Couple at RSNA 2009 6557 6Siemens Introduces Its New Power Couple at RSNA 2009 6557 7